Infectious Disease Control

Receipt Of Approval From The UAE For Phase II/III Clinical Trial Of Sequential Booster Vaccination For ReCOV

TAIZHOU, China, April 13, 2022 /PRNewswire/ -- Jiangsu Recbio Technology Co., Ltd. (the"Company", together with its subsidiaries, the "Group",Stock code:2179.HK) is pleased to announce that the Company has received approval from the Ministry of Health and Prevention of theUnited Arab Emirates ("U...

2022-04-13 12:56 3155

HIGH-TECH DROIDS UNITE AT DORSETT WANCHAI

To Ensure Guests a Safe & Healthy Quarantine Stay From HKD990nett per night with Daily 3 Meals & USD24-110 Cash Credits HONG KONG, April 13, 2022 /PRNewswire/ -- The award-winning Dorsett Wanchai, Hong Kong  c...

2022-04-13 12:24 3018

Successful Passing Of The EU Qualified Person Audit Of The Group's Manufacturing Facility For ReCOV In Taizhou

TAIZHOU, China, April 11, 2022 /PRNewswire/ -- The board of directors of Jiangsu Recbio Technology Co., Ltd. (the "Company", together with its subsidiaries, the "Group",Stock code:2179.HK) is pleased to announce that, on April 9, 2022, the Company has received the European Union (EU) Qualified Pe...

2022-04-11 16:05 1961

Novavax and Serum Institute of India Receive Emergency Use Authorization for Novavax' COVID-19 Vaccine in Thailand

GAITHERSBURG, Md., and PUNE, India, April 8, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and Serum Institute of India Pvt. Ltd. (SII), the world's largest vaccine ...

2022-04-08 21:00 4874

Tianlong COVID-19 Solution Safeguards Passengers In Jakarta International Airport In Indonesia

XI'AN, China, April 8, 2022 /PRNewswire/ -- Tianlong's integrated PCR lab solution is installed inJakarta's international airport in Indonesia to help conduct nucleic acid testing for inbound and outbound passengers. Since its installation inSeptember 2021, Tianlong's COVID-19 solution has helped...

2022-04-08 15:04 2688

New very-high-sensitivity rapid antigen test kits hit Australian market

New COVID-19 Medriva Rapid Antigen Test kits with very high- sensitivity now available inAustralia MELBOURNE, Australia, April 8, 2022 /PRNewswire/ -- Medriva; https://medriva.com , a leading global manufacturer of COVID-19 testing and vaccination products, announced the Aus...

2022-04-08 06:00 2872

Everest Medicines Enters into an MOU for Partnership with China Resources Pharmaceutical Group for its mRNA Vaccine Business

China Resources Pharmaceutical Group ("CR Pharma") intends to make strategic equity investment for Everest's mRNA technology platform Partnership with CR Pharma will provide local support to navigate China regulatory pathways across mRNA vaccine platform, first in the advancement of Everest's po...

2022-04-07 07:30 2979

Ceres Nanosciences Establishes Sixteen Wastewater-Based Epidemiology Centers of Excellence Under NIH RADx Initiative

MANASSAS, Va., April 6, 2022 /PRNewswire/ -- Ceres Nanosciences (Ceres), a privately held company that makes innovative products to improve life science research and diagnostic testing, is announcing the establishment of six new wastewater-based epidemiology centers of excellence. The new centers...

2022-04-06 19:37 2672

Indonesia's G20 Health Working Group (HWG) Meeting Series Work Towards Standardization of Global Health Protocols

JAKARTA, April 5, 2022 /PRNewswire/ -- Assuming the presidency in the upcoming G20 summit,Indonesia has begun the Health Working Group (HWG) meeting series that took place on28-30 March 2022 in Yogyakarta, Indonesia. Indonesia's Ministry of H...

2022-04-05 09:00 3757

Indonesia's Ministry of Health Discussed a Universal Vaccine Passport and Verifier for International Travelers

JAKARTA, April 4, 2022 /PRNewswire/ -- Assuming the presidency in the upcoming G20 summit,Indonesia has begun the Health Working Group (HWG) meeting series that took place on28-30 March 2022 in Yogyakarta, Indonesia. Indonesia's Ministry of H...

2022-04-04 23:35 2007

CanSinoBIO's COVID-19 mRNA Vaccine Receives Approval of Clinical Trial Application in China

TIANJIN, April 4, 2022 /PRNewswire/ -- CanSino Biologics Inc. ("CanSinoBIO" of "the Company") (SSE: 688185, HKEX: 06185) today announced that the National Medical Products Administration ofChina ("NMPA") granted approval for the clinical trial application of its COVID-19 mRNA vaccine inChina. Pr...

2022-04-04 08:30 5125

Brii Bio Presents New Data on BRII-835 (VIR-2218) in Chinese Patients with Chronic Hepatitis B at APASL 2022

New data demonstrate BRII-835 (VIR-2218) was well tolerated with notable reductions in serum HBsAgobserved in the Chinese patients infected with chronic hepatitis B DURHAM, N.C. and BEIJING, March 31, 2022 /PRNewswire/ -- Brii Biosciences Limited ("Brii Bio" o...

2022-03-31 18:05 2736

Novavax Submits Request to Expand Conditional Marketing Authorization of COVID-19 Vaccine in the European Union to Adolescents (Ages 12-17)

* If granted, Nuvaxovid™ COVID-19 Vaccine (recombinant, adjuvanted) would be the first protein-based option for adolescents aged 12-17 years inEurope GAITHERSBURG, Md., March 31, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializi...

2022-03-31 18:00 2803

Brii Bio Announces Strategic Partnership with Sinopharm to Advance Commercialization of Long-Acting COVID-19 Neutralizing Antibody Therapy, Amubarvimab/Romlusevimab Combination, in China

DURHAM, N.C. and BEIJING, March 30, 2022 /PRNewswire/ -- Brii Biosciences Limited ("Brii Bio" or the "Company", stock code: 2137.HK) a multi-national company developing innovative therapies for diseases with significant unmet medical needs and large public heal...

2022-03-30 08:05 2764

CCTV+: Peng Liyuan addresses World Tuberculosis Day video conference

BEIJING, March 24, 2022 /PRNewswire/ -- Peng Liyuan, wife of Chinese President Xi Jinping and World Health Organization (WHO) goodwill ambassador for Tuberculosis (TB) and HIV/AIDS, addressed the World Tuberculosis Day video conference on Thursday.   Global tuberculosis control...

2022-03-25 11:04 2054

PolyU startup iMeddy provides free video medical consultation to COVID-19 patients to help fight the pandemic leveraging innovative technology

HONG KONG, March 24, 2022 /PRNewswire/ -- Amid the severity of the fifth wave of the COVID-19 pandemic, a startup nurtured by The Hong Kong Polytechnic University (PolyU), known as iMeddy, is providing a free video medical consultation service on its pioneering online healthcare platform to a quo...

2022-03-24 20:29 1983

Early Detection Saves Lives: HPV Testing Kits - Chula's Innovation for Women's Health

BANGKOK, March 24, 2022 /PRNewswire/ -- Cervical cancer is the second most common cancer in Thai women age 30-60, after breast cancer, with 10,000 new cases per year, and claiming as many as 5,000 lives annually. Though curable if detected early, many women are afraid of getting tested due to the...

2022-03-24 08:15 3456

Novavax and Serum Institute of India Announce First Emergency Use Authorization of Novavax' COVID-19 Vaccine in Adolescents ≥12 to <18 in India

* First authorization of Novavax' COVID-19 vaccine in adolescent population received * Covovax™ (SARS-CoV-2 rS Protein (COVID-19) recombinant spike protein Nanoparticle Vaccine) is the first protein-based COVID-19 vaccine authorizedfor adolescents ≥12 to <18 inIndia * Authorization highligh...

2022-03-23 09:31 2667

Brii Biosciences Provides Corporate Update and Reports Full Year 2021 Financial Results

– Advancing key programs in HBV, CNS, and HIV – – Received first BLA approval for COVID-19 Treatment in China and added to China's latest COVID-19 Diagnosis and Treatment Guidelines– – Multiple clinical value drivers expected across the portfolio in 2022 and beyond – – Cash, bank balances, an...

2022-03-23 07:20 3773

INDICAID COVID-19 Rapid Antigen At-Home Test Receives FDA Emergency Use Authorization (EUA) for Over-the-Counter (OTC), Asymptomatic, Non- Prescription Use

GARDEN GROVE, Calif., March 22, 2022 /PRNewswire/ -- PHASE Scientific International, LTD  (PHASE Scientific), a high-growth biotech company founded by bioengineers fromUCLA, announces that its INDICAID® COVID-19 Rapid Antigen At-Home Test (INDICAID® OTC) recei...

2022-03-23 00:00 1889
1 ... 14151617181920 ... 78

Week's Top Stories